Determination and Validation of Lung EpiCheck; a Multianalyte Assay for Lung Cancer Prediction, A Case-Control Study
Summary
The study is designed to develop a simple blood test for the early detection of lung cancer in patients at high risk of developing the disease.
Eligibility
Eligible gender: Male, Female, Transgender, Other
Eligible ages: 50 to 80
Accepts healthy participants: Yes
Inclusion criteria:
Participants 50-80 years old, with current or past smoking of cigarettes, that meet one of the following criteria may be eligible for this study:
• Participants that are going to have, or have had a low-dose CT for lung cancer screening within 60 days
• Participants with a high suspicion of lung cancer going for biopsy or surgery
• Participants with a confirmed diagnosis of stage I and II non-small cell lung cancer that have not undergone surgery or any other treatment.
Exclusion criteria:
Participants with known diagnosis or treatment of any previous cancer, including lung cancer, in the past 5 years
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Dr. Alain Tremblay at atrembla@ucalgary.ca or 403-210-3866.
Principal investigator:
Alain Tremblay
Clinical trial:
No
REB-ID:
HREBA.CC-22-0163